Insider Transactions last 24 months for Zymeworks Inc.  -  NSDQ: ZYME

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Galbraith KennethChair & CEO01/12/2026DSDirectCOM30,424$22.67$689,818.56226,842
Galbraith KennethChair & CEO01/12/2026AMDirectCOM64,000$0.00$0.00257,266
Moore Paul AndrewChief Scientific Officer01/12/2026DSDirectCOM9,560$22.67$216,758.6648,497
Moore Paul AndrewChief Scientific Officer01/12/2026AMDirectCOM17,666$0.00$0.0058,057
Smith Jeffrey T LEVP & Chief Medical Officer01/12/2026DSDirectCOM9,310$22.67$211,090.2926,708
Smith Jeffrey T LEVP & Chief Medical Officer01/12/2026AMDirectCOM17,666$0.00$0.0036,018
Hollywood MarkEVP & Chief Operating Officer01/12/2026DSDirectCOM6,120$22.67$138,761.82132,913
Hollywood MarkEVP & Chief Operating Officer01/12/2026AMDirectCOM17,666$0.00$0.00139,033
Patterson Leone DEVP, Chief Bus & Fin Officer01/06/2026AADirectCOM459$10.55$4,842.45459
Moore Paul AndrewChief Scientific Officer01/05/2026DSDirectCOM10,821$25.10$271,573.5540,391
Moore Paul AndrewChief Scientific Officer01/05/2026AMDirectCOM20,000$0.00$0.0051,212
Moore Paul AndrewChief Scientific Officer01/05/2026DSDirectCOM9,289$25.10$233,125.1031,212
Moore Paul AndrewChief Scientific Officer01/05/2026AMDirectCOM17,168$0.00$0.0040,501
Galbraith KennethChair & CEO01/05/2026DSDirectCOM31,686$25.10$795,220.37193,266
Galbraith KennethChair & CEO01/05/2026AMDirectCOM66,666$0.00$0.00224,952
Galbraith KennethChair & CEO01/05/2026DSDirectCOM22,657$25.10$568,620.46158,286
Galbraith KennethChair & CEO01/05/2026AMDirectCOM47,668$0.00$0.00180,943
Smith Jeffrey T LEVP & Chief Medical Officer01/05/2026DSDirectCOM10,538$25.10$264,471.1318,352
Smith Jeffrey T LEVP & Chief Medical Officer01/05/2026AMDirectCOM20,000$0.00$0.0028,890
Galbraith KennethChair & CEO12/22/2025DSDirectCOM47,528$27.02$1,284,311.12133,275
Galbraith KennethChair & CEO12/22/2025AMDirectCOM100,000$0.00$0.00180,803
Ciongoli Gregory AustinDirector08/12/2025AADirectCOM415,000$12.02$4,988,300.00488,500
Ecor1 Capital, LlcDirector06/26/2025DFIndirectCOM41$12.71$521.1122,970,388
Ecor1 Capital, LlcDirector06/26/2025AXIndirectCOM5,086,480$0.00$508.6522,970,388
Ecor1 Capital, LlcDirector05/19/2025APIndirectCOM5,919$11.78$69,738.2517,883,908
1   2  3  Next Last  You are at page 1 of 3 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel